Assessment of potential drug-drug interactions at hospital discharge

被引:22
作者
Bertoli, R. [1 ,2 ]
Bissig, M. [3 ]
Caronzolo, D. [4 ]
Odorico, M. [5 ]
Pons, M. [5 ]
Bernasconi, E. [1 ,2 ,5 ]
机构
[1] Osped Reg Lugano, Serv Consulenza Farmaci, CH-6903 Lugano, Switzerland
[2] Osped Reg Lugano, Ctr Reg Farmacovigilanza, CH-6903 Lugano, Switzerland
[3] Osped Reg Lugano, Serv Farm Osped EOFARM, CH-6903 Lugano, Switzerland
[4] Osped San Giovanni Bellinzona, Serv Farm Osped EOFARM, Bellinzona, Switzerland
[5] Osped Reg Lugano, Med Serv, CH-6903 Lugano, Switzerland
关键词
potential drug-drug interactions; hospital discharge; clinical pharmacy; MEDICAL PATIENTS; EVENTS;
D O I
10.4414/smw.2010.13043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The evaluation of the prevalence of potential drug-drug interactions and assessment of their clinical relevance in patients' discharge medication in the medical ward of a community teaching hospital. The relevant clinical information was reported to the treating physicians. Methods: 200 patients at discharge from a medical ward were included. Prescribed drugs were analysed for interactions using commercially available software (Pharmavista (R)). Clinical pharmacists and a physician assessed the clinical relevance of detected interactions, eliminated those which were not considered clinically relevant and formulated recommendations for those considered clinically relevant. A written recommendation was given to the physician to provide rapid feedback before discharge. Results: The median age of the 200 patients studied was 69 years. At discharge, patients took an average of 7 different drugs. 62.5% of patients had at least one potential drug-drug interaction. In total, 373 potential drug-drug interactions were identified: 223 (60%) of minor severity, 143 (38%) of moderate severity and 7 (2%) of major severity. Conclusions: A computerised drug-drug interaction program (detection) together with clinical pharmacological experience (interpretation/evaluation) can be useful for decreasing the number of potentially harmful drug combinations. This approach may lead to an improvement in the quality of prescription, reducing possible risks and thus contributing to patient safety.
引用
收藏
页数:5
相关论文
共 15 条
[1]  
BONETTI PO, 2000, SCHWEIZ RUNDSCH MED, V89, P182
[2]   Adverse drug events in hospitalized patients - Excess length of stay, extra costs, and attributable mortality [J].
Classen, DC ;
Pestotnik, SL ;
Evans, RS ;
Lloyd, JF ;
Burke, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04) :301-306
[3]  
DICASTRI A, 1995, THERAPIE, V50, P259
[4]   Potential drug-drug interactions in the medication of medical patients at hospital discharge [J].
Egger, SS ;
Drewe, J ;
Schlienger, RG .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 58 (11) :773-778
[5]   Hospital prescribing errors: epidemiological assessment of predictors [J].
Fijn, R ;
Van den Bemt, PMLA ;
Chow, M ;
De Blaey, CJ ;
De Jong-Van den Berg, LTW ;
Brouwers, JRBJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (03) :326-331
[6]   Can you prevent adverse drug events after hospital discharge? [J].
Forster, AJ .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 174 (07) :921-922
[7]   Adverse drug events occurring following hospital discharge [J].
Forster, AJ ;
Murff, HJ ;
Peterson, JF ;
Gandhi, TK ;
Bates, DW .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2005, 20 (04) :317-323
[8]  
Forster AJ, 2004, CAN MED ASSOC J, V170, P345
[9]   EPIDEMIOLOGY OF DRUG-DRUG INTERACTIONS AS A CAUSE OF HOSPITAL ADMISSIONS [J].
JANKEL, CA ;
FITTERMAN, LK .
DRUG SAFETY, 1993, 9 (01) :51-59
[10]  
Köhler GI, 2000, INT J CLIN PHARM TH, V38, P504